A Phase I/Ib Trial of PD 0332991 (Palbociclib) and T-DM1 in HER2-Positive Advanced Breast Cancer After Trastuzumab and Taxane Therapy
Barbara Haley, Kiran Batra, Sunati Sahoo, Thomas Froehlich, Dawn Klemow, Nisha Unni, Chul Ahn, Melissa Rodríguez, Melanie Hullings, Arthur E. Frankel
Topics & Concepts
MedicineTrastuzumabPalbociclibTaxaneOncologyInternal medicineBreast cancerPertuzumabCancerMetastatic breast cancerAdvanced Breast Cancer TherapiesHER2/EGFR in Cancer ResearchCancer-related Molecular Pathways